Bellazzi R, Larizza C, Montani S, Riva A, Stefanelli M, d'Annunzio G, Lorini R, Gomez E J, Hernando E, Brugues E, Cermeno J, Corcoy R, de Leiva A, Cobelli C, Nucci G, Del Prato S, Maran A, Kilkki E, Tuominen J
Dipartimento di Informatica e Sistemistica, Università di Pavia, via Ferrata 1, I-27100 Pavia, Italy.
Comput Methods Programs Biomed. 2002 Aug;69(2):147-61. doi: 10.1016/s0169-2607(02)00038-x.
In the context of the EU funded Telematic Management of Insulin-Dependent Diabetes Mellitus (T-IDDM) project, we have designed, developed and evaluated a telemedicine system for insulin dependent diabetic patients management. The system relies on the integration of two modules, a Patient Unit (PU) and a Medical Unit (MU), able to communicate over the Internet and the Public Switched Telephone Network. Using the PU, patients are allowed to automatically download their monitoring data from the blood glucose monitoring device, and to send them to the hospital data-base; moreover, they are supported in their every day self monitoring activity. The MU provides physicians with a set of tools for data visualization, data analysis and decision support, and allows them to send messages and/or therapeutic advice to the patients. The T-IDDM service has been evaluated through the application of a formal methodology, and has been used by European patients and physicians for about 18 months. The results obtained during the project demonstration, even if obtained on a pilot study of 12 subjects, show the feasibility of the T-IDDM telemedicine service, and seem to substantiate the hypothesis that the use of the system could present an advantage in the management of insulin dependent diabetic patients, by improving communications and, potentially, clinical outcomes.
在欧盟资助的胰岛素依赖型糖尿病远程信息管理(T-IDDM)项目背景下,我们设计、开发并评估了一个用于胰岛素依赖型糖尿病患者管理的远程医疗系统。该系统依赖于两个模块的集成,即患者单元(PU)和医疗单元(MU),它们能够通过互联网和公共交换电话网络进行通信。使用患者单元,患者可以自动从血糖监测设备下载监测数据,并将其发送到医院数据库;此外,在日常自我监测活动中患者会得到支持。医疗单元为医生提供了一组用于数据可视化、数据分析和决策支持的工具,并允许他们向患者发送信息和/或治疗建议。T-IDDM服务已通过应用正式方法进行评估,并已被欧洲患者和医生使用了约18个月。在项目示范期间获得的结果,即使是在对12名受试者的试点研究中获得的,也显示了T-IDDM远程医疗服务的可行性,并且似乎证实了这样的假设,即通过改善沟通以及潜在地改善临床结果,使用该系统可能在胰岛素依赖型糖尿病患者的管理中具有优势。